ALK-Abelló A/S (OTC:AKBLF) Stock Price Up 1.8% – Should You Buy?

ALK-Abelló A/S (OTC:AKBLF)’s stock price traded up 1.8% during trading on Tuesday . The company traded as high as $36.10 and last traded at $36.10. 100 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 274 shares. The stock had previously closed at $35.45.

ALK-Abelló A/S Stock Performance

The business has a 50-day simple moving average of $34.73 and a 200-day simple moving average of $31.10.

About ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.